Levels of FGF23 were higher in participants with metabolic syndrome or at an increased risk of metabolic syndrome,218 indicating that FGF23 underlies cardiovascular risk via either phosphate or adverse lipid metabolism. This evidence concerns the gene FGF23 and metabolic syndrome.